# MSC2015103B in Solid Tumors

> **NCT01453387** · PHASE1 · TERMINATED · sponsor: **EMD Serono** · enrollment: 28 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** MSC2015103B
- **DRUG:** MSC2015103B

## Key facts

- **NCT ID:** NCT01453387
- **Lead sponsor:** EMD Serono
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Due to an administrative reason
- **Last updated:** 2017-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01453387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01453387, "MSC2015103B in Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01453387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*